Sandbox/AIRSG: Difference between revisions
Line 53: | Line 53: | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | D01 | | | | | | | | | D01=<div style="width: | {{familytree | | | | | | | D01 | | | | | | | | | D01=<div style="width:24em">'''Identify cardinal findings that increase the pretest probability of [[aortic regurgitation]]'''</div><br><div style="width:30em; text-align:left"> '''Acute [[aortic regurgitation]]''' <br> ❑ Low pitched early diastolic murmur | ||
: ❑ Best heard at the right 2nd intercostal space | : ❑ Best heard at the right 2nd intercostal space | ||
❑ Decreased or absent [[S1]] <br> ❑ Increased P2 <br> ❑ Sudden onset of [[dyspnea]] | ❑ Decreased or absent [[S1]] <br> ❑ Increased P2 <br> ❑ Sudden onset of [[dyspnea]] | ||
Line 62: | Line 62: | ||
❑ [[Wide pulse pressure]] (≥ 60 mmHg) <br> ❑ [[S3]] <br> ❑ [[Corrigan's pulse]]: a rapid upstroke and collapse of the [[carotid artery]] pulse </div>}} | ❑ [[Wide pulse pressure]] (≥ 60 mmHg) <br> ❑ [[S3]] <br> ❑ [[Corrigan's pulse]]: a rapid upstroke and collapse of the [[carotid artery]] pulse </div>}} | ||
{{familytree | | | | | | | |!| | | | | | | | | | }} | {{familytree | | | | | | | |!| | | | | | | | | | }} | ||
{{familytree | | | | | | | A01 | | | | | | | | | | A01= <div style="float: left; text-align: left; width: | {{familytree | | | | | | | A01 | | | | | | | | | | A01= <div style="float: left; text-align: left; width: 24em; padding:1em;">'''Does the patient have any of the following findings that require urgent management?'''<br> | ||
❑ [[Tachycardia]] <br> ❑ [[Hypotension]]<br>❑ [[Altered mental status]]<br>❑ [[Tachypnea]] <br> ❑ [[Oliguria]] <br> ❑ [[Cold extremities]]</div>}} | ❑ [[Tachycardia]] <br> ❑ [[Hypotension]]<br>❑ [[Altered mental status]]<br>❑ [[Tachypnea]] <br> ❑ [[Oliguria]] <br> ❑ [[Cold extremities]]</div>}} | ||
{{family tree | | | | |,|-|-|^|-|-|-|.| }} | {{family tree | | | | |,|-|-|^|-|-|-|.| }} | ||
Line 76: | Line 76: | ||
{{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| | | | X01 | | | | | | | |X01='''What is the etiology based on clinical findings and [[echocardiography|<span style="color:white;">echo</span>]]?''' }} | {{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| | | | X01 | | | | | | | |X01='''What is the etiology based on clinical findings and [[echocardiography|<span style="color:white;">echo</span>]]?''' }} | ||
{{family tree | |,|-|-|^|-|-|.| | | | | | | }} | {{family tree | |,|-|-|^|-|-|.| | | | | | | }} | ||
{{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| D01 | | | | D02 | | | | | D01=<div style="float: left; text-align: center; width: | {{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| D01 | | | | D02 | | | | | D01=<div style="float: left; text-align: center; width:23em "> '''[[Aortic dissection|<span style="color:white;">Type A aortic dissection</span>]]'''</div><br> | ||
---- | ---- | ||
<div style="float: left; text-align: left"> '''Diagnostic clues:''' <br> ❑ [[Chest pain|<span style="color:white;">Chest pain</span>]] of the following characteristics: | <div style="float: left; text-align: left"> '''Diagnostic clues:''' <br> ❑ [[Chest pain|<span style="color:white;">Chest pain</span>]] of the following characteristics: | ||
Line 89: | Line 89: | ||
: ❑ [[Marfan syndrome|<span style="color:white;">Marfan syndrome</span>]] | : ❑ [[Marfan syndrome|<span style="color:white;">Marfan syndrome</span>]] | ||
: ❑ [[The heart in mixed connective tissue disorder|<span style="color:white;">Connective tissue disorder</span>]] </div> | : ❑ [[The heart in mixed connective tissue disorder|<span style="color:white;">Connective tissue disorder</span>]] </div> | ||
|D02=<div style="float: left; text-align: center; width: | |D02=<div style="float: left; text-align: center; width:24em"> '''[[Infective endocarditis|<span style="color:white;">Infective endocarditis</span>]]'''</div><br> | ||
---- | ---- | ||
<div style="float: left; text-align: left">'''Diagnostic clues:''' <br> ❑ Persistent [[fever|<span style="color:white;">fever</span>]] <br> ❑ New valvular regurgitation murmur <br> ❑ Previous [[blood culture|<span style="color:white;">blood culture</span>]] positive <br> ❑ [[Vegetation|<span style="color:white;">Vegetations</span>]] found on [[TTE|<span style="color:white;">TTE</span>]] <br> ❑ High risk factors: | <div style="float: left; text-align: left">'''Diagnostic clues:''' <br> ❑ Persistent [[fever|<span style="color:white;">fever</span>]] <br> ❑ New valvular regurgitation murmur <br> ❑ Previous [[blood culture|<span style="color:white;">blood culture</span>]] positive <br> ❑ [[Vegetation|<span style="color:white;">Vegetations</span>]] found on [[TTE|<span style="color:white;">TTE</span>]] <br> ❑ High risk factors: | ||
Line 102: | Line 102: | ||
❑ Order [[blood culture|<span style="color:white;">blood cultures</span>]] (if they have not been previously ordered) <br> </div>}} | ❑ Order [[blood culture|<span style="color:white;">blood cultures</span>]] (if they have not been previously ordered) <br> </div>}} | ||
{{family tree | |!| | | | | |!| | | | | | | | }} | {{family tree | |!| | | | | |!| | | | | | | | }} | ||
{{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| E01 | | | | E02 | | | | | | | E01=<div style="float: left; text-align: Left; width: | {{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| E01 | | | | E02 | | | | | | | E01=<div style="float: left; text-align: Left; width:23em ">❑ '''Immediate surgical intervention''' </div> |E02=<div style="float: left; text-align: Left;"> ❑ '''Immediate surgical intervention''' </div> }} | ||
{{family tree | |!| | | | | |!| | | | | | | | }} | {{family tree | |!| | | | | |!| | | | | | | | }} | ||
{{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| F01 | | | | F02 | | | | | | | F01=<div style="float: left; text-align: Left; width: | {{family tree |boxstyle=background: #FA8072; color: #F8F8FF;| F01 | | | | F02 | | | | | | | F01=<div style="float: left; text-align: Left; width:23em "> '''Click here for [[aortic dissection resident survival guide|<span style="color:white;">aortic dissection resident survival guide </span>]]'''</div> |F02=<div style="float: left; text-align: Left;"> '''Click here for [[infective endocarditis resident survival guide|<span style="color:white;">infective endocarditis resident survival guide</span>]]''' </div> }} | ||
{{Family tree/end}} | {{Family tree/end}} | ||
Revision as of 13:02, 18 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Aortic Regurgitation Resident Survival Guide Microchapters |
---|
Overview |
Causes |
FIRE |
Diagnosis |
Treatment |
Do's |
Don'ts |
Overview
Aortic regurgitation (AR) refers to the retrograde or backward flow of blood from the aorta into the left ventricle during diastole.[1][2][3][4] The presentation depends on the response and adaptability of the left ventricle to the increased diastolic volume, in chronic AR the left ventricle has adapted by dilatation of its walls. However, in acute AR, a rapid increase in the diastolic volume is not tolerated by a normal size ventricle and this could lead to cardiogenic shock. The most common causes of acute aortic regurgitation are aortic dissection and infective endocarditis and the preferred treatment in both cases surgical intervention. The most common cause of chronic AR is bicuspid aortic valve and the treatment will depend on the stage of the disease. Acute AR is a life-threatening condition and must be recognized and treated promptly.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Bicuspid aortic valve
- Senile or degenerative calcific aortic valve disease[5]
- Hypertension
- Idiopathic dilatation of the aorta
- Myxomatous degeneration
- Rheumatic fever
Click here for the complete list of causes.
FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention. The algorithm below is based on the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease.[6][7]
Boxes in salmon color signify that an urgent management is needed.
Abbreviations: ECG: electrocardiogram; TTE: transthoracic echocardiography; TEE: transesophageal echocardiography; S1: first heart sound; P2: second heart sound, pulmonary component; S3: third heart sound
Identify cardinal findings that increase the pretest probability of aortic regurgitation Acute aortic regurgitation ❑ Low pitched early diastolic murmur
❑ Decreased or absent S1
❑ S3 ❑ Corrigan's pulse: a rapid upstroke and collapse of the carotid artery pulse | |||||||||||||||||||||||||||||||||||
Does the patient have any of the following findings that require urgent management? ❑ Tachycardia ❑ Hypotension ❑ Altered mental status ❑ Tachypnea ❑ Oliguria ❑ Cold extremities | |||||||||||||||||||||||||||||||||||
YES | NO | ||||||||||||||||||||||||||||||||||
Initiate resuscitation measures: ❑ Secure airway ❑ Administer oxygen ❑ 2 wide bore IV access ❑ ECG monitor ❑ Monitor vitals continuously ❑ ICU admission Initiate medical therapy ❑ Administer vasodilator (IV nitroprusside), AND ❑ Administer inotropic agents (IV dobutamine)
| Proceed to Complete Diagnostic Approach | ||||||||||||||||||||||||||||||||||
What is the etiology based on clinical findings and echo? | |||||||||||||||||||||||||||||||||||
Diagnostic clues: ❑ Chest pain of the following characteristics:
❑ Syncope
❑ Aortic root dissection found on TTE | Diagnostic clues: ❑ Persistent fever ❑ New valvular regurgitation murmur ❑ Previous blood culture positive ❑ Vegetations found on TTE ❑ High risk factors:
| ||||||||||||||||||||||||||||||||||
❑ Immediate surgical intervention | ❑ Immediate surgical intervention | ||||||||||||||||||||||||||||||||||
Click here for aortic dissection resident survival guide | Click here for infective endocarditis resident survival guide | ||||||||||||||||||||||||||||||||||
Diagnosis
A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[6][7]
Abbreviations: BP: blood pressure; CXR: chest X-ray; ECG: electrocardiogram; LV: left ventricle; MI: myocardial infarction; TTE: transthoracic echocardiography; TEE: transesophageal echocardiography; TAVR: transcatheter aortic valve replacement; S1: first heart sound; S2: second heart sound; S3: third heart sound;
Acute Aortic Regurgitation
Characterize the symptoms: ❑ Sudden and severe dyspnea
❑ Syncope ❑ Weakness ❑ Myalgias | |||||||||||||||||||||||||||||||||||||||||||
Inquire about past medical history: ❑ Cardiac disease: ❑ Rheumatic fever
| |||||||||||||||||||||||||||||||||||||||||||
Examine the patient: Vitals
Cardiovascular examination
❑ Hyperdynamic apical impulse but in normal location
Respiratory examination | |||||||||||||||||||||||||||||||||||||||||||
Order labs and tests: ❑ TTE (most important evaluation test) (Class I; Level of Evidence: B)
❑ ECG
❑ Blood culture (if suspected infective endocarditis) ❑ Cardiac enzymes (Troponin, CK-MB) | |||||||||||||||||||||||||||||||||||||||||||
Determine the etiology of the acute aortic regurgitation | |||||||||||||||||||||||||||||||||||||||||||
Diagnostic clues: ❑ Chest pain of the following characteristics:
❑ Syncope
❑ Previous history of: | Diagnostic clues: ❑ Persistent fever ❑ New valvular regurgitation murmur ❑ Positive blood culture ❑ Vegetations found on TTE ❑ High risk factors:
| Other causes | |||||||||||||||||||||||||||||||||||||||||
Click here for aortic dissection resident survival guide | Click here for infective endocarditis resident survival guide | ||||||||||||||||||||||||||||||||||||||||||
Chronic Aortic Regurgitation
Characterize the symptoms: ❑ Asymptomatic ❑ Dyspnea on exertion ❑ Orthopnea ❑ Paroxysmal nocturnal dyspnea ❑ Palpitations ❑ Chest pain ❑ Shortness of breath ❑ Cough ❑ Altered mental status ❑ Syncope ❑ Fatigue | |||||||||||||||||||||||||||||||||||||||||||||
Inquire about past medical history: ❑ Cardiac disease: ❑ Rheumatic fever ❑ Pulmonary disease ❑ Trauma ❑ Syphilis ❑ Ankylosing spondylitis ❑ Acromegaly ❑ Marfan syndrome ❑ Ehlers-Danlos syndrome ❑ Giant cell arteritis ❑ Takayasu's arteritis ❑ Previous cardiac surgery | |||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: Vitals
Cardiovascular examination
❑ Search for other characteristic signs suggestive of aortic regurgitation
Respiratory examination | |||||||||||||||||||||||||||||||||||||||||||||
Order imaging studies: ❑ TTE (most important evaluation test) (Class I; Level of Evidence: B)
![]()
❑ ECG | |||||||||||||||||||||||||||||||||||||||||||||
Classify aortic regurgitation based on the following findings on TTE: ❑ Vena contracta ❑ Jet/LVOT ❑ Regurgitant volume ❑ Regurgitant fraction ❑ Effective regurgitant orifice | |||||||||||||||||||||||||||||||||||||||||||||
❑ No regurgitation | Mild (Stage B) ❑ Vena contracta <0.3 cm ❑ Jet/LVOT <25% ❑ Regurgitant volume <30 mL/beat ❑ Regurgitant fraction <30% ❑ Effective regurgitant orifice <0.10 cm² | Moderate (Stage B) ❑ Vena contracta 0.3-0.6 cm ❑ Jet/LVOT 25-64% ❑ Regurgitant volume 30-59 mL/beat ❑ Regurgitant fraction 30-49% ❑ Effective regurgitant orifice 0.10-0.29 cm² | Severe ❑ Vena contracta >0.6 cm ❑ Jet/LVOT ≥ 65% ❑ Regurgitant volume ≥60 mL/beat ❑ Regurgitant fraction ≥50% ❑ Effective regurgitant orifice ≥ 0.30 cm² ❑ Holodiastolic flow reversal in the proximal abdominal aorta | ||||||||||||||||||||||||||||||||||||||||||
Asymptomatic | Symptomatic (Stage D) | ||||||||||||||||||||||||||||||||||||||||||||
Treatment
Acute Aortic Regurgitation
Shown below is an algorithm for the treatment of acute aortic regurgitation according to the 2014 AHA/ACC Guidelines for the Management of Valvular Heart Disease[6][9] and the 2010 ACCF/AHA Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease[10]
Determine the etiology and the grade of regurgitation | |||||||||||||||||||||||||||||||||
Mild or moderate regurgitation (Stage B) | Severe regurgitation (Stage C or D) | Mild or moderate regurgitation (Stage B) | Severe regurgitation (Stage C or D) | ||||||||||||||||||||||||||||||
Early mitral valve closure† is present? | Replacement of supra-coronary ascending aorta | Aortic root replacement, OR Valve-sparing aortic root replacement | |||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||
❑ ICU care ❑ Perform surgery if:
| If presence of mitral regurgitation:
❑ Perform surgery immediately (< 4 hours) If absence of mitral regurgitation: ❑ Perform surgery in less than 24 hours | ||||||||||||||||||||||||||||||||
† Early mitral valve closure refers to the closure of the mitral valve before the QRS due to an increased diastolic left ventricle pressure. Grade I occurs when it happens before QRS but after the P wave. Grade II is the mitral valve closure before the P wave. [9]
Chronic Aortic Regurgitation
Shown below is an algorithm summarizing the treatment approach to chronic aortic regurgitation according to the 2014 AHA/ACC Guidelines on the Management of Valvular Heart Disease.[6][7]
Abbreviations: TTE: transthoracic echocardiography; AVR: aortic valve replacement; CCB: calcium channel blocker; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blocker
Interpret results from TTE | |||||||||||||||||||||||||||||||||||||||||||||||||||
No regurgitation (Stage A) | Progressive regurgitation (Stage B) Mild ❑ Vena contracta <0.3 cm ❑ Jet/LVOT <25% ❑ Regurgitant volume <30 mL/beat ❑ Regurgitant fraction <30% ❑ Effective regurgitant orifice <0.10 cm² Moderate ❑ Vena contracta 0.3-0.6 cm ❑ Jet/LVOT 25-64% ❑ Regurgitant volume 30-59 mL/beat ❑ Regurgitant fraction 30-49% ❑ Effective regurgitant orifice 0.10-0.29 cm² | Severe regurgitation ❑ Vena contracta >0.6 cm ❑ Jet/LVOT ≥ 65% ❑ Regurgitant volume ≥60 mL/beat ❑ Regurgitant fraction ≥50% ❑ Effective regurgitant orifice ≥ 0.30 cm² ❑ Holodiastolic flow reversal in the proximal abdominal aorta | |||||||||||||||||||||||||||||||||||||||||||||||||
Asymptomatic patients ❑ Control hypertension preferably with
| Asymptomatic (Stage C) | Symptomatic (Stage D) | |||||||||||||||||||||||||||||||||||||||||||||||||
❑ Perform a periodic echocardiogram (Class I; Level of Evidence:B)
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Perform a periodic echocardiogram every 6 - 12 months (Class I; Level of Evidence: B) | ❑ Schedule for AVR (Class I; Level of Evidence: B) ❑ Administer ACE inhibitors/ARBs or beta blockers if patient has contraindications for surgery | ||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
❑
Don'ts
❑ Do not use beta blockers in aortic regurgitation that is not caused by aortic dissection as it will block the compensatory tachycardia.
❑ Do not use intra-aortic baloon counterpulsation in severe acute AI as it will increase the aortic diastolic pressure and the regurgitant volume.
❑ Do not give antibiotics to patients with known VHD before blood cultures are obtained for unexplained fever. (Class III; Level of Evidence: C)
❑ Do not give ACE inhibitors to pregnant patients with aortic regurgitation. (Class III; Level of Evidence: B)
❑
❑
❑
❑
❑
❑
❑
References
- ↑ Connolly HM, Crary JL, McGoon MD; et al. (1997). "Valvular heart disease associated with fenfluramine-phentermine". N. Engl. J. Med. 337 (9): 581–8. doi:10.1056/NEJM199708283370901. PMID 9271479.
- ↑ Weissman NJ (2001). "Appetite suppressants and valvular heart disease". Am. J. Med. Sci. 321 (4): 285–91. doi:10.1097/00000441-200104000-00008. PMID 11307869.
- ↑ Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007). "Dopamine agonists and the risk of cardiac-valve regurgitation". N. Engl. J. Med. 356 (1): 29–38. doi:10.1056/NEJMoa062222. PMID 17202453.
- ↑ Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007). "Valvular heart disease and the use of dopamine agonists for Parkinson's disease". N. Engl. J. Med. 356 (1): 39–46. doi:10.1056/NEJMoa054830. PMID 17202454.
- ↑ Nishimura, RA. (2002). "Cardiology patient pages. Aortic valve disease". Circulation. 106 (7): 770–2. PMID 12176943. Unknown parameter
|month=
ignored (help) - ↑ 6.0 6.1 6.2 6.3 Nishimura, R. A.; Otto, C. M.; Bonow, R. O.; Carabello, B. A.; Erwin, J. P.; Guyton, R. A.; O'Gara, P. T.; Ruiz, C. E.; Skubas, N. J.; Sorajja, P.; Sundt, T. M.; Thomas, J. D. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000031. ISSN 0009-7322.
- ↑ 7.0 7.1 7.2 Bonow, R. O.; Carabello, B. A.; Chatterjee, K.; de Leon, A. C.; Faxon, D. P.; Freed, M. D.; Gaasch, W. H.; Lytle, B. W.; Nishimura, R. A.; O'Gara, P. T.; O'Rourke, R. A.; Otto, C. M.; Shah, P. M.; Shanewise, J. S. (2008). "2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–e661. doi:10.1161/CIRCULATIONAHA.108.190748. ISSN 0009-7322.
- ↑ Williams BR, Steinberg JP (2006). "Images in clinical medicine. Müller's sign". The New England Journal of Medicine. 355 (3): e3. doi:10.1056/NEJMicm050642. PMID 16855259. Retrieved 2012-04-15. Unknown parameter
|month=
ignored (help) - ↑ 9.0 9.1 Hamirani, Y. S.; Dietl, C. A.; Voyles, W.; Peralta, M.; Begay, D.; Raizada, V. (2012). "Acute Aortic Regurgitation". Circulation. 126 (9): 1121–1126. doi:10.1161/CIRCULATIONAHA.112.113993. ISSN 0009-7322.
- ↑ Hiratzka, L. F.; Bakris, G. L.; Beckman, J. A.; Bersin, R. M.; Carr, V. F.; Casey, D. E.; Eagle, K. A.; Hermann, L. K.; Isselbacher, E. M.; Kazerooni, E. A.; Kouchoukos, N. T.; Lytle, B. W.; Milewicz, D. M.; Reich, D. L.; Sen, S.; Shinn, J. A.; Svensson, L. G.; Williams, D. M. (2010). "2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine". Circulation. 121 (13): e266–e369. doi:10.1161/CIR.0b013e3181d4739e. ISSN 0009-7322.